Gsk Share Discussion Threads

[sogoesit] 30/8/2019 10:16

The FTSE-100 is currently a cable play, imv.
But on GSK there's reistance at current $41.7/$42.2 on the ADR's.
Upside from there would be to about $44 (£18/share at $1.22/£).
Some market talking heads say cable at $1.20/$1.22 prices "no deal brexit" in.
AIMV

[sogoesit] 30/8/2019 09:57

Agree, tim 3.
But I'm closing today for £1.30 profit on my long trade.
Will re-visit if there's a breakout between 1722 and 1749 at longer term resistance.
Good luck!

[tradermichael] 30/8/2019 09:56

Who would buy at >1700p? (Especially this side of 31 Oct …. ;0)

[aimtoretire] 30/8/2019 09:35

GSK has been more or less aligned with FTSE 100 since 1st August. I'm guessing this will continue until some news specific to GSK causes it to break away up or down. Difficult for those of us wanting to buy - unless you've got a crystal ball.

[tim 3] 29/8/2019 21:48

If it breaks 1730 likely to see another leg up imo.

[abdullla] 29/8/2019 09:14

This tree shaking looks to be working in opposite direction

[abdullla] 27/8/2019 14:10

It looks like GSK is tracking the Ftse

[tradermichael] 27/8/2019 09:15

Its just shaking out the novice buyers who bought on the way to the top.

There could be a short-term double bottom here, on 1650p, or possibly a triple bottom.

[abdullla] 27/8/2019 08:50

All the gains made on the good news have now evaporated

[philanderer] 23/8/2019 10:02

Good news.

"GlaxoSmithKline was in the green after the pharmaceuticals giant said a clinical trial of its blood cancer treatment met its primary goal."

Morning everyone.

[xxxxxy] 23/8/2019 08:58

Bailed out. No easy route back in.Lots of patience required now.

[tradermichael] 23/8/2019 08:41

Right now, 1650p looks attractive!

[abdullla] 23/8/2019 08:30

TM,what do you think the bargain price is

[tradermichael] 23/8/2019 08:14

Too much good news about to get a bargain price at the moment:

GlaxoSmithKline PLC (GSK.LN) said Friday that headline results from its DREAMM-2 study for treatment of multiple myeloma, a type of blood cancer, were positive.
The pharmaceutical company said the two-arm study of its treatment belantamab mafodotin met its primary objective and demonstrated a clinically meaningful overall response rate.
Safety and tolerability was consistent with that observed in the DREAMM-1 study, GlaxoSmithKline said.
Data from the DREAMM-2 study will be the basis for regulatory filings starting later this year, the company said. Belantamab mafodotin is on track for regulatory submission by the end of 2019, it said.

[abdullla] 23/8/2019 08:03

Buy now or you miss the train

[prambigear] 22/8/2019 17:08

No-one buying anywhere

[abdullla] 22/8/2019 09:26

GSK going up but no one buying here

[tradermichael] 21/8/2019 11:18

GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the submission of a Japanese New Drug Application (JNDA) to the Ministry of Health, Labour and Welfare seeking marketing approval for daprodustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), for the treatment of patients with renal anaemia due to chronic kidney disease (CKD).

Dr Hal Barron, Chief Scientific Officer and President R&D, GSK said, “Around 3.5 million patients in Japan have anaemia associated with renal disease which can result in weakness and fatigue. We are excited about our first regulatory filing for daprodustat which, if approved, will provide a new and convenient oral treatment option for these patients.”

[sogoesit] 20/8/2019 09:23

Dial 1700 for a £1 profit going long, imv!
(I'm not a short term trader 'tho).

[abdullla] 20/8/2019 09:05

Fatal also could mean dial 999 :)

[sogoesit] 20/8/2019 08:57

"Fatal"?
See your Risk Management Manual, please.
;-)

[abdullla] 20/8/2019 08:30

TM,with the GSK share price shooting up daily what is the future entry point for those having sold and now sitting on the cash,re-entry at this point of time could be fatal?

[sogoesit] 18/8/2019 13:27

Some divis coming my way next week (RIO).
Looks like this a good candidate for accumulation.

[sicker] 16/8/2019 09:58

Thanks for info TM :-)